Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Frassoni

Showing results (161-170 of 215) with videos related to

Pageof 22
Sort By:
Haematologica|July 1, 1997
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemiaA M Carella, F Frassoni, J Melo, et al.
Bone Marrow Transplantation|September 1, 1999
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, F Frassoni, et al.
Haematologica|January 12, 2000
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuriaA M Raiola, M T Van Lint, T Lamparelli, et al.
British Journal of Haematology|December 3, 1999
Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapyG Piaggio, M Podestà, A Pitto, et al.
Bone Marrow Transplantation|November 1, 1996
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationO Ringdén, M Labopin, E Gluckman, et al.
British Journal of Haematology|February 13, 2001
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell doseA Dominietto, A M Raiola, M T van Lint, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Interferon-alpha protects Philadelphia-negative progenitors from exhaustion in chronic myeloid leukemia patients with cytogenetic responseF Frassoni, M Podestà, G Piaggio, et al.
British Journal of Haematology|January 29, 2000
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantationA Bacigalupo, V Vitale, R Corvò, et al.
Blood|January 7, 1998
Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemiaD Ben-Yehuda, S Krichevsky, E A Rachmilewitz, et al.
Transplantation Proceedings|February 1, 1997
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, E Gluckman, et al.
Pageof 22

Showing results (161-170 of 215) with videos related to

Sort By:
Pageof 22
Haematologica|July 1, 1997
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemiaA M Carella, F Frassoni, J Melo, et al.
Bone Marrow Transplantation|September 1, 1999
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, F Frassoni, et al.
Haematologica|January 12, 2000
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuriaA M Raiola, M T Van Lint, T Lamparelli, et al.
British Journal of Haematology|December 3, 1999
Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapyG Piaggio, M Podestà, A Pitto, et al.
Bone Marrow Transplantation|November 1, 1996
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationO Ringdén, M Labopin, E Gluckman, et al.
British Journal of Haematology|February 13, 2001
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell doseA Dominietto, A M Raiola, M T van Lint, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Interferon-alpha protects Philadelphia-negative progenitors from exhaustion in chronic myeloid leukemia patients with cytogenetic responseF Frassoni, M Podestà, G Piaggio, et al.
British Journal of Haematology|January 29, 2000
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantationA Bacigalupo, V Vitale, R Corvò, et al.
Blood|January 7, 1998
Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemiaD Ben-Yehuda, S Krichevsky, E A Rachmilewitz, et al.
Transplantation Proceedings|February 1, 1997
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, E Gluckman, et al.
Pageof 22